Travis Mickle, President & CEO, Director at Zevra Therapeutics, holds 171.77K shares in Zevra Therapeutics (Ticker: ZVRA). Most recently, Travis Mickle Bought $13,000 shares of Zevra Therapeutics on May 25, 2022 for an estimated value of 56.98K.
What is the percentage of profitable transactions made by Travis Mickle?
The percentage of profitable transactions made by Travis Mickle is 43%.
What is the average return per transaction made by Travis Mickle?
The average return per transaction made by Travis Mickle is 68.60%.
What stocks does Travis Mickle hold?
Travis Mickle holds: ZVRA stocks.
What was Travis Mickle’s latest transaction?
Travis Mickle latest transaction was an Informative Buy of $56.98K.
What was Travis Mickle's most profitable transaction?
Travis Mickle’s most profitable transaction was an Informative Buy of ZVRA stock on April 15, 2015. The return on the trade was 800.00%.
What is Travis Mickle's role in Zevra Therapeutics?
Travis Mickle's role in Zevra Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.